MedTrace Logo

Home Monitoring in Cardiac Resynchronisation Therapy

NCT00376116 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 513

Last updated 2008-11-17

No results posted yet for this study

Summary

In spite of success in the management of heart failure, repetitive rehospitalisation and high mortality rate remain a serious problem. Recent studies, especially the COMPANION trial, have demonstrated that cardiac resynchronisation therapy (CRT) reduces mortality and rehospitalisation in heart failure patients. There is also evidence that telemonitoring of heart failure patients potentially reduces both mortality and morbidity. Recently, a Home Monitoring (HM) function has been integrated into BIOTRONIK CRT-defibrillators and CRT-pacemakers with a view of harnessing the powerful combination of CRT with close remote monitoring of heart failure patients. It is possible now to transmit predefined parameters on a daily basis from the implanted devices to a web-based platform accessible by patients' physicians. Our study evaluates clinical usefulness of Biotronik HM function in CRT-defibrillators and CRT-pacemakers.

Conditions

  • Heart Failure, Congestive

Interventions

DEVICE

Cardiac resynchronisation therapy

DEVICE

Implantable cardioverter-defibrillator

Sponsors & Collaborators

  • Biotronik SE & Co. KG

    lead INDUSTRY

Principal Investigators

  • Stefan Sack, Associate Prof. Dr. · Division of Cardiology, University of Essen, Germany

  • Vincent Paul, MD · Cardiology Department, St. Peter's Hospital, Chertsey Surrey, United Kingdom

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-03-31
Completion
2008-11-30

Countries

  • Austria
  • Czechia
  • France
  • Germany
  • Israel
  • Italy
  • Latvia
  • Netherlands
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00376116 on ClinicalTrials.gov